Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 14, 2026, 9:28 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 25–48 of 337 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Parent Child Relationship Clear all

Conditions: Disruptive Behavior, Attention-deficit Hyperactivity, Oppositional Defiant Disorder
Interventions: Garmin; Device
Lead sponsor: Mayo Clinic; Other
Eligibility: 3 Years to 99 Years
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Behavior Problem, Parenting
Interventions: Parent Child Interaction Therapy, Child Parent Psychotherapy; Behavioral
Lead sponsor: Florida International University; Other
Eligibility: 2 Years to 5 Years
Enrollment: 144 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2021
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Alzheimer's Disease
Interventions: ABT-126; Drug
Lead sponsor: AbbVie (prior sponsor, Abbott); Industry
Eligibility: 55 Years to 90 Years
Enrollment: 349 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 5
States / cities: Delray Beach, Florida • West Palm Beach, Florida • Elk Grove Village, Illinois + 2 more

Conditions: Oppositional Defiant Disorder, Conduct Disorder, Disruptive Behavior Disorder Nos
Interventions: Parent-Child Interaction Therapy (PCIT), Internet-delivered PCIT (I-PCIT); Behavioral
Lead sponsor: Florida International University; Other
Eligibility: 3 Years to 5 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2016
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Short Bowel Syndrome, Intestinal Failure, Home Parenteral Nutrition
Interventions: Not listed
Lead sponsor: Children's Hospital Los Angeles; Other
Eligibility: 3 Months to 6 Years
Enrollment: 58 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2023
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: HER2-positive Metastatic Breast Cancer
Interventions: Alpelisib, Tucatinib, Fulvestrant; Drug
Lead sponsor: Criterium, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 4
States / cities: Aurora, Colorado • Fort Collins, Colorado • New Orleans, Louisiana + 1 more

Conditions: Advanced Solid Tumours With Androgen Receptor Pathway as a Potential Factor
Interventions: AZD5312; Drug
Lead sponsor: AstraZeneca; Industry
Eligibility: 18 Years to 130 Years
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 3
States / cities: Sarasota, Florida • Nashville, Tennessee • Milwaukee, Wisconsin

Conditions: The Primary Disease Process Being Studied is Shoulder OA and the Effect of an All Polyethelene Glenoid Component on Shoulder Arthroplasty
Interventions: Shoulder arthroplasty with anchor peg glenoid; Device
Lead sponsor: Knoxville Orthopedic Clinic; Other
Eligibility: 40 Years to 80 Years
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Knoxville, Tennessee

Conditions: Bipolar Disorder (BD), Bipolar Disorder I or II, Bipolar Disorder Family Members, Screening Tool
Interventions: Co-design Workshop (Observational Procedure), Alpha Testing (Observational Procedure), Beta Testing (Observational Procedure), Youth Screening Pathway & Brief Follow-Up Interview (Observational Procedure); Other
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 7 Years and older
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Parent-Child Relations, Parenting, Child Mental Disorder
Interventions: Project Support; Behavioral
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 5 Years to 12 Years
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Childhood Obesity, Obesity
Interventions: Mother with obesity, daughter with obesity, Mother with obesity, daughter without obesity, Mother without obesity, daughter with obesity, Mother without obesity, daughter without obesity, Mother with obesity, son with obesity, Mother with obesity, son without obesity, Mother without obesity, son with obesity, Mother without obesity, son without obesity, Father with obesity, daughter with obesity, Father with obesity, daughter without obesity, Father without obesity, daughter with obesity, Father without obesity, daughter without obesity, Father with obesity, son with obesity, Father with obesity, son without obesity, Father without obesity, son with obesity, Father without obesity, son without obesity; Other
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years and older
Enrollment: 1,973 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Ocular Surface Disease, Dry Eye Syndrome (DES)
Interventions: (Xiidra®) Lifitegrast Ophthalmic Solution 5.0%; Drug
Lead sponsor: Pittsburgh Research Institute; Other
Eligibility: 18 Years and older
Enrollment: 36 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026
U.S. locations: 1
States / cities: Sewickley, Pennsylvania

Conditions: Attention Deficit Hyperactivity Disorder, Parent-Child Relations, Child Behavior, Parenting
Interventions: Promoting Engagement with ADHD Pre-Kindergarteners; Behavioral
Lead sponsor: Lehigh University; Other
Eligibility: 3 Years to 5 Years
Enrollment: 180 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2026
U.S. locations: 1
States / cities: Bethlehem, Pennsylvania

Conditions: Early Child Well-being, Parental Stress, Family Economic Security, Parental/Caregiver Health, Mental Health
Interventions: Guaranteed Income ($500/monthly), Active Comparison ($20/monthly); Behavioral
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years and older
Enrollment: 599 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Carcinoma, Non-Small-Cell Lung
Interventions: Amivantamab, Docetaxel; Drug
Lead sponsor: Janssen Research & Development, LLC; Industry
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 6
States / cities: Irvine, California • Los Alamitos, California • Orange, California + 3 more

Conditions: Parent-Child Relations
Interventions: Family Foundations Coparenting Program; Behavioral
Lead sponsor: Penn State University; Other
Eligibility: 18 Years and older
Enrollment: 497 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2002 – 2007
U.S. locations: 1
States / cities: University Park, Pennsylvania

Conditions: Painful Diabetic Neuropathy
Interventions: NRD135SE.1, Placebo; Drug · Other
Lead sponsor: James P. Rathmell, MD; Other
Eligibility: 18 Years and older
Enrollment: 127 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 26
States / cities: San Diego, California • Clermont, Florida • Gainesville, Florida + 18 more

Conditions: Diabetes Mellitus, Type 2
Interventions: Ultrasound Vagus Nerve Stimulation (DECIMA); Device
Lead sponsor: Aucta Technologies, Inc.; Industry
Eligibility: 21 Years to 60 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Scottsdale, Arizona

Conditions: Depressive Symptoms, Emotional Depression, Depression, Parent Child Relationship, Parent-Child Relationship, Parent-Child Relations, Stress Disorder, Post Traumatic, PTSD, Parenting, Child Behavior, Emotional Regulation, Emotion Regulation
Interventions: Parenting-STAIR Modular (PSTAIR-M), Treatment as Usual (TAU); Behavioral
Lead sponsor: New York University; Other
Eligibility: 18 Years and older
Enrollment: 243 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 4
States / cities: Colorado Springs, Colorado • Silver Spring, Maryland • Lawton, Oklahoma + 1 more

Conditions: Sleep, Parenting, Marital Relationship, Parent-Child Relations
Interventions: Infant sleep-adapted coparenting intervention; Behavioral
Lead sponsor: Penn State University; Other
Eligibility: 1 Month to 65 Years
Enrollment: 216 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2025
U.S. locations: 1
States / cities: State College, Pennsylvania

Conditions: Interpersonal Relations
Interventions: SSGRIN-Parent Guide; Behavioral
Lead sponsor: Duke University; Other
Eligibility: 8 Years to 12 Years
Enrollment: 240 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2012
U.S. locations: 2
States / cities: Cary, North Carolina • Durham, North Carolina

Conditions: Stress, Psychological, Post-Traumatic Stress Disorder, Major Injury
Interventions: DEF-only, DEF + COPE; Behavioral
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: Up to 5 Years
Enrollment: 57 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Ciliary Body and Choroid Melanoma, Medium/Large Size, Extraocular Extension Melanoma, Iris Melanoma, Stage IIB Melanoma, Stage IIC Melanoma, Stage IIIA Melanoma, Stage IIIB Melanoma, Stage IIIC Melanoma, Stage IV Melanoma
Interventions: tyrosinase peptide, gp100 antigen, MART-1 antigen, incomplete Freund's adjuvant, Montanide ISA 51 VG, sargramostim, laboratory biomarker analysis; Biological · Drug · Other
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2007
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Enuresis, Nocturnal
Interventions: Manual Trigger, Normal; Behavioral
Lead sponsor: Gina Lockwood; Other
Eligibility: 5 Years to 15 Years
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2023
U.S. locations: 1
States / cities: Iowa City, Iowa

Search by objective public record fields.

Monitoring of Sleep and Behavior of Children 3-7 Years Old Receiving Parent-Child Interaction Therapy With the Help of Artificial Intelligence

Early Intervention For Families Experiencing Homelessness: A Randomized Trial Comparing Two Parenting Programs

This is a Safety and Tolerability Study Evaluating a New Treatment for Subjects With Mild to Moderate Alzheimer's Disease

Evaluating the Feasibility of Internet-delivered PCIT

Infant & Toddler Short Gut Feeding Outcomes Study

Clinical Trial of Alpelisb and Tucatinib in Patients With PIK3CA-Mutant HER2+ Metastatic Breast Cancer.

Phase I Open Label Dose Escalation Study to Investigate the Safety & Pharmacokinetics of AZD5312 in Patients With Androgen Receptor Tumors

This is a 2 Year Follow up Clinical and Radiographic Analysis of a Novel All Polyethelene Glenoid Component in Standard Total Shoulder Arthroplasty.

FOCUS Bipolar: Families Opening Conversations for Understanding Signs

Examine the Feasibility and Acceptability of Project Support

Weight Stigma by Association in Parent-Child Dyads

This is a Single Center, Open-label Prospective Study to Evaluate the Effect of Xiidra® (Lifitegrast Ophthalmic Solution 5.0%) on Tear Film Biomarkers in Dry Eye

Project PEAK: Early Intervention for ADHD

Mixed Methods Evaluation of the Pomona Household Universal Grant (HUG) Program

A Study of Combination Therapy With Amivantamab and Docetaxel in Participants With Metastatic Non-small Cell Lung Cancer

Family Foundations Coparenting Pilot Trial

EPPIC-Net: Novaremed Painful Diabetic Peripheral Neuropathy ISA

Acute Study of Effect of Ultrasound Vagus Nerve Stimulation on Glycemia

Parenting-STAIR Modular for Military Fathers and OCONUS Families

Coparenting, Infant Sleep, and Infant Development

Parent Treatment for Child Social Adjustment

Intervention to Reduce Stress in 0-5 Year Olds With Burns

Vaccine Therapy With or Without Sargramostim in Treating Patients Who Have Undergone Surgery for Melanoma

Enuresis Alarm - Is a Manual Trigger System Beneficial?